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Abstract
Biofilm is an aggregate of consortium bacteria that adhere to each other on a surface. It is usually protected by the
exopolysaccharide layer. Various invasive medical procedures, such as catheterization, endotracheal tube installation,
and contact lens utilization, are vulnerable to biofilm infection. The National Institute of Health (NIH) estimates 65% of
all microbial infections are caused by biofilm. Periplasmic α-amylase (MalS) is an enzyme that hydrolyzes α-1, 4glicosidic bond in glycogen, starch, and others related polysaccharides in periplasmic space. Another protein called
hemolysin-α (HlyA) is a secretion signal protein on C terminal of particular peptide in gram negative bacteria. We
proposed a novel recombinant plasmid expressing α-amylase and hemolysin-α fusion in pSB1C3 which is cloned into
E.coli to enable α-amylase excretion to extracellular for degrading biofilm polysaccharides content, as in starch agar.
Microtiter assay was performed to analyze the reduction percentage of biofilm by adding recombinant E.coli into
media. This system is more effective in degrading biofilm from gram positive bacteria i.e.: Bacillus substilis (30.21%)
and Staphylococcus aureus (24.20%), and less effective degrading biofilm of gram negative i.e.: Vibrio cholera
(5.30%), Pseudomonas aeruginosa (8.50%), Klebsiella pneumonia (6.75%) and E. coli (-0.6%). Gram positive bacteria
have a thick layer of peptidoglycan, causing the enzyme to work more effectively in degrading polysaccharides.

Abstrak
Ekspresi dan Penelitian Fungsi Protein Fusi α-Amilase dan Hemolisin-α sebagai suatu Penerapan dalam
Penurunan Polisakarida Biofilm. Biofilm adalah sekumpulan bakteria yang saling melekat satu sama lain pada suatu
permukaan. Biofilm ini biasanya dilindungi oleh lapisan eksopolisakarida. Berbagai prosedur medis yang pro-aktif,
seperti kateterisasi, instalasi alat bantuan pernafasan, dan penggunaan lensa kontak mata, rentan terhadap infeksi
biofilm. NIH (National Institute of Health – Institusi Kesehatan Nasional) memperkirakan 65% dari semua infeksi
mikroba disebabkan oleh biofilm. Enzim α-amilase periplasma (MalS) merupakan suatu enzim yang menghidrolisis α-1,
ikatan 4-glikosidik dalam glikogen, zat tepung, dan lainnya terkait polisakarida pada ruang periplasma. Protein lainnya
yang disebut hemolisin-α (HlyA) merupakan protein sinyal sekresi pada terminal C dari peptida tertentu dalam bakteria
gram-negatif. C merupakan protein sinyal sekresi pada terminal C dari peptida tertentu dalam bakteria gram-negatif.
Kami mengusulkan suatu plasmid rekombinan baru mengekspresikan fusi α-amilase and hemolisin-α dalam pSB1C3
yang diklon menjadi E. coli untuk memungkinkan ekskresi α-amilase ke luar sel tubuh (ekstraselular) untuk menurunkan
isi polisakarida biofilm, seperti dalam agar zat tepung. Tes dengan tabung kecil dilakukan untuk menganalisis persentase
pengurangan biofilm dengan menambahkan E. coli rekombinan ke dalam media. Sistem ini lebih efektif dalam
menurunkan tingkat biofilm dari bakteria gram-positif, seperti Bacillus substilis (30.21%) dan Staphylococcus aureus
(24.20%), dan kurang efektif menurunkan tingkat biofilm dari gram-negatif, Vibrio cholera (5.30%), Pseudomonas
aeruginosa (8.50%), Klebsiella pneumonia (6.75%), dan E. coli (-0.6%). Bakteria gram-positif mempunyai lapisan
peptidoglikan yang tebal, menyebabkan enzim untuk bekerja lebih efektif dalam menurunkan tingkat polisakarida.
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1. Introduction
Biofilms are dense packed microbial cells that grow on
surface and covered with secreted polymers [1]. The
National Institute of Health (NIH) estimates 65% of all
microbial infections are caused by biofilm. Biofilm
causes 80% of chronic inflammation and it leads to devicerelated infection (DRI) [2]. According to the National
Allergy and Infectious Disease (NAID) 2010, two million
cases of medical device-related infection caused by
biofilm infection [3]. Gram positive and gram negative
bacteria, such as Enterococcus faecalis, Staphylococcus
aureus, Staphylococcus epidermidis, Staphylococcus
viridians, Escherichia coli, Psedomonas aeruginosa,
Klebsiella pneumonia, and Proteus mirabilis, have been
successfully isolated from various medical devices [4].
Biofilm is difficult to destroy because the bacteria inside
the biofilm are highly resistant to antibiotics. Pipes,
catheters, nasogastric tubes, and other medical devices
that have been colonized by biofilms are usually replaced
to remove the contaminant [5].
Synthetic biology is a new field with growing trends of
novel solutions for old problems. We proposed a novel
solution for biofilm infection by reprogramming bacteria
using synthetic biology principles. The engineered E.
coli is capable to produce α-amylase and secrete the
enzyme to degrade biofilm in medical devices.
Alpha-amylase is an essential enzyme for α-glucan
metabolism. It is also capable to catalyze the hydrolysis
of α-1, 4-glicosidic bond in glycogen, starch, and some
others related polysaccharides. MalS is a 1967 bp gene
responsible for expression of α-amylase in E. coli strain
K12 [6-8]. HlyA is a signal peptide found in C-terminal
signal sequence of alpha-hemolysin. Gram negative
bacteria use HlyA protein tag to secrete proteins via
Type I secretion pathway. Fusion of the HlyA signal
peptide with the target protein caused the secretion of
target protein to extracellular medium in a single step.
HlyA interacts with the cytoplasmic region of the
preformed HlyB-D complex. After the binding of the
HlyA secretion signal by the HlyB-D complex, HlyD
induces the TolC interaction and exports the target
protein to the extracellular space [9]. A former study
which was conducted by Bisi DC & Lample DJ shows
that anti-bovine serum albumin (BSA) scFv fused with
HlyA tag has been successfully secreted into extracellular
compartment [10].

2. Methods
Biofilm-producing bacteria are obtained from Clinical
Microbiology Laboratory, the Faculty of Medicine
Universitas Indonesia, consisting of E. coli, Pseudomonas
aeruginosa, Vibrio cholera, Klebsiella pneumonia,
Staphylococcus aureus, and Bacillus substillis. We used
pSB1C3 plasmid as the expression vector. The plasmid
Makara J. Technol.

carries chloramphenicol resistance gene and pUC19derived pMB1 origin of replication. The pSB1C3 has
terminators in the downstream of its multiple cloning
sites to hinder transcription [11]. We used a strong
constitutive promoter, whose activity is not governed by
any transcription factors. Universal primers used to amplify
all the genes were VF2 (5’-tgccacctgacgtctaagaa-3’) and
VR (5'-attaccgcctttgagtgagc-3’).
The promoter, α-amylase, and hemolysin-α gene sequences
are obtained from the International Genetically Engineered
Machine (IGEM) standard registry of biological parts.
The experiment was conducted in a biosafety level two
(BSL-2) laboratory at the Institute of Human Virology
and Cancer Biology (IHVCB), Universitas Indonesia.
Determining restriction sites and the primer design.
The restriction sites used in this experiment were EcoRI,
NotI, XbaI, DpnI, and PstI. The codon optimization was
performed in order to enable E. coli cells to express the
genes of interest.
Vector plasmid preparation. Plasmids were digested
with restriction enzyme. The pSB1C3 with red fluorescent
protein (RFP) was digested with EcoRI and the gene of
interest was inserted into the vector. Plasmids containing
the desired gene from “iGEM kit” were transformed into
E. coli Top10. The E. coli was then cultured and the
plasmids were isolated using Qiagen® plasmid isolation
kit. Obtained plasmids were then digested and ligated
into pSB1C3 using the standard cloning protocol.
Competent cells. The bacteria were cultured on Luria
Bertani (LB) broth and incubated overnight. Overnight
cultures were then added into 30 mL fresh media LB
and incubated for 1.5 hours (OD 600 nm). The culture
was put on ice for 30 minutes, then centrifuged 3500
rpm for 10 minutes at 4 °C. Supernatant was discarded.
6 mL MgCl2 100 mM was added and the cultures were
incubated for one hour at 4 °C, then it was centrifuged
again on 3500 rpm for 10 minutes. The supernatant was
discarded and 0.2 mL MgCl2 100 mM was added. The
competent cells were ready to be used [12].
Transformation of plasmid into E. coli Top10. The
competent cells were thawed and labeled for each
concentration. 1 µL of DNA and 50 µL of competent
cells were added into each tube before chilled in ice for
30 minutes. The cells were heat-shocked by placing into
42 °C water bath for 1 minute. The tubes were immediately
transferred back to ice and incubated for 5 minutes. 200
µL of SOC media was added per tube and incubated at
37 °C for 2 hours. 20 µL from each tube was added into
the appropriate plate [12].
Verification of DNA plasmids. Verification of DNA
plasmids was done by isolating the plasmids from E.
coli culture. The isolated plasmids were then visualized
December 2016 | Vol. 20 | No. 3
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using the electrophoresis method to prove that the
desired genes were successfully inserted to the plasmids.
The electrophoresis was using 0.8% agarose gel in 100
mL 0.5× TAE with 100 mV voltages and run for 30
minutes.

on electrophoresis to confirm the length of plasmid.
Alpha amylase-hemolysin-α-fusion gene has a length of
2298 bp. The resulting electrophoresis band was located
near 2500 bp, confirming that α-amylase and hemolysinα have been fused (Figure 2).

Secretion test of alpha-amylase (MalS) on starch
agar. Starch (1.5 g) was dissolved with 200 mL ddH2O
and mixed with 300 mL LB agar evenly by heating it in
an oven. The wild type E. coli, recombinant E. coli
containing plasmid for MalS and HlyA, and E. coli
containing empty plasmids were then incubated for 18
hours and 24 hours. The agar was then washed using
iodine. In this experiment, we compared the activity of
α-amylase under the control of a strong promoter, αamylase without a promoter and wild type E.coli as the
negative control.

The starch agar assay using classic iodine-polysaccharide
interaction was performed to prove that recombinant E.
coli cells were able to secrete α-amylase and degrade
the starch. The degraded starch will be shown as a clear
zone. The clear zones indicate that iodine molecules can
no longer bind to the polysaccharides since those have
been degraded into their monomer. The longer the
incubation time, the more vivid a clear zone appears to
be, as shown at the figure below (Figures 3, 4).

Anti-biofilm activity assay. Biofilm-producing bacteria
were incubated in 50 mL LB Broth for 48 hours at 37 °C
in a 200 rpm dynamic incubator. The cultures were then
diluted using fresh broth with 1:100 ratio. The diluted
cultures were placed into 96-well plate with each well
containing 200 µl of culture, and further incubated for
20-28 hours in a 37 °C static incubator. The LB media
were then discarded, leaving biofilm on the bottom of
the well plate. Recombinant E. coli was then added into
the 96-well plate and incubated for 6 hours. Then, the
plates were washed gently and stained with 0.5% crystal
violet, aspirated using 2% acetic acid in 96% ethanol
(v/v). The absorbance was quantified in 595 nm ELISA
Reader [13].

The result shows that the supernatant of the culture is
able to degrade the starch. This infers that the α-amylase
and hemolysin-α secretion tag recombinant protein has
been expressed and secreted into the medium. However, we
cannot absolutely conclude that the clear zone was formed
because the enzymes were excreted by recombinant E.
coli. This is because the wild type E. coli also has
functional α-amylase in its periplasmic region, but not
exported into extracellular media. If the bacteria are to

Micro titer assay for efficacy of biofilm removal. The
micro titer assay was performed according to Molobela,
et al. (2010) to quantify the biofilm removal by adding
α-amylase [14]. The percentage of reduction in Eq. (1)
was used as a measurement to evaluate the efficacy of
this enzyme.

(C − B ) − (T − B ) x 100%
(C − B )

(1)

Figure 1. Red and White Colony Selection under UV (White
Colony Denoted by Encircled Label)

Where B denotes the average absorbance per well for
blank (no biofilm, no treatment); C denotes the average
absorbance per well for control wells (biofilm, no
treatment), and T denotes the average absorbance per
well for treated wells (biofilm and treatment).

3. Results and Discussion
The resulting red and white colonies were screened to
select the E. coli which carries the desired inserts
(Figure 1). The white colonies indicate interested
plasmids were successfully inserted into pSB1C3
plasmid backbone because the expression of RFP was
interrupted with the expression of desired genes. After
that, the cultures from selected colonies are visualized
Makara J. Technol.

Figure 2. The Electrophoresis Pattern of Single Restriction
of MalS-HlyA Fusion by Enzyme EcoRI
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24.20% of degradation respectively, higher than those
of gram negative bacteria, such as Vibrio cholerae
(5.3%), Pseudomonas aeruginosa (8.50%), Klebsiella
pneumonia (6.75%), and E.coli (-0.6%).

Figure 3. Incubation of 18 Hours of E. coli Expressing
Recombinant Plasmid after Iodine Flooding
Treatment; WT (Wild Type), SMH (Strong
Promoter-MalS-HlyA), MH (MalS-HlyA). Red
Arrow Pointed the Clear Zone

Gram positive bacteria have a thick layer of peptidoglycan.
Peptidoglycan consists of glycan backbone of muramic
acid and glucosamine (both N-acetylated), and also other
cell wall polymers, such as teichoic acid, polysaccharides,
and peptidoglycolipids [15]. In contrast, gram negative
bacteria have thinner peptidoglycan. It is suspected that
more substrate for alpha amylase available causes an
increase in an alpha amylase activity. Direct inoculation
of E. coli on to E. coli cells does not cause biofilm
degradation. In Figure 6, E. coli shows a negative
percentage which means that E. coli cells undergo an
overgrowth to form biofilm. However, future research
should be done to purify and further characterize the αamylase protein.

Figure 5. Biofilm Staining. The Darker Blue Color Indicates
more Biofilm Residing The Well

Figure 4. Incubation of 24 hours of E. coli Expressing
Recombinant Plasmid after Iodine Flooding
Treatment. The Clear Zone Appears more
Vivid than Incubation of 18 Hours. Red Arrow
Pointed the Clear Zone

be lysed, a clear zone may be formed because of the
activity of periplasmic α-amylase. However, over
expression of α-amylase under the control of a strong
promoter as we did in our experiment can degrade
polysaccharides more efficiently.
The reduction of biofilm quantified by micro titer assay
shows surprising results as in Figure 5. Biofilm removal
in gram positive bacteria is noticeably greater than in
gram negative bacteria. In Figure 6, Bacillus substilis
and Staphylococcus aureus biofilm show 30.21% and
Makara J. Technol.

Figure 6. Percentage of Biofilm Reduction
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4. Conclusions
Recombinant plasmid expressing protein fusion of αamylase and hemolysin-α is able to be cloned in E. coli
cells and works functionally. The protein fusion works
more effectively in biofilm degradation of gram positive
bacteria than gram negative bacteria. However, protein
extraction should be performed to obtain the recombinant
protein. For further applications, a comprehensive study
is needed to assess the effectivity of recombinant protein
erradicating biofilm in various medical devices.
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